Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1989 1
1990 1
1991 2
1992 1
1993 1
1994 1
1995 2
1996 1
1997 2
1998 1
1999 1
2000 1
2001 2
2002 1
2003 2
2005 3
2006 2
2007 3
2008 2
2009 2
2011 3
2012 1
2013 1
2015 2
2016 1
2018 2
2019 2
2020 3
2021 3
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
The 'immunologic advantage' of HIV-exposed seronegative individuals.
Miyazawa M, Lopalco L, Mazzotta F, Lo Caputo S, Veas F, Clerici M; ESN Study Group. Miyazawa M, et al. Among authors: veas f. AIDS. 2009 Jan 14;23(2):161-75. doi: 10.1097/QAD.0b013e3283196a80. AIDS. 2009. PMID: 19098485 Review. No abstract available.
2019-nCoV in context: lessons learned?
Kock RA, Karesh WB, Veas F, Velavan TP, Simons D, Mboera LEG, Dar O, Arruda LB, Zumla A. Kock RA, et al. Among authors: veas f. Lancet Planet Health. 2020 Mar;4(3):e87-e88. doi: 10.1016/S2542-5196(20)30035-8. Epub 2020 Feb 7. Lancet Planet Health. 2020. PMID: 32035507 Free PMC article. No abstract available.
Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts.
Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, Tambyah PA, Blumberg L, Yapi R, Al-Abri S, Pinto TCA, Yeboah-Manu D, Haider N, Asogun D, Velavan TP, Kapata N, Bates M, Ansumana R, Montaldo C, Mucheleng'anga L, Tembo J, Mwaba P, Himwaze CM, Hamid MMA, Mfinanga S, Mboera L, Raj T, Aklillu E, Veas F, Edwards S, Kaleebu P, McHugh TD, Chakaya J, Nyirenda T, Bockarie M, Nyasulu PS, Wejse C, Muyembe-Tamfum JJ, Azhar EI, Maeurer M, Nachega JB, Kock R, Ippolito G, Zumla A. Petersen E, et al. Among authors: veas f. Int J Infect Dis. 2022 Jan;114:268-272. doi: 10.1016/j.ijid.2021.11.040. Epub 2021 Dec 1. Int J Infect Dis. 2022. PMID: 34863925 Free PMC article. No abstract available.
Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future.
Kapata N, Ihekweazu C, Ntoumi F, Raji T, Chanda-Kapata P, Mwaba P, Mukonka V, Bates M, Tembo J, Corman V, Mfinanga S, Asogun D, Elton L, Arruda LB, Thomason MJ, Mboera L, Yavlinsky A, Haider N, Simons D, Hollmann L, Lule SA, Veas F, Abdel Hamid MM, Dar O, Edwards S, Vairo F, McHugh TD, Drosten C, Kock R, Ippolito G, Zumla A. Kapata N, et al. Among authors: veas f. Int J Infect Dis. 2020 Apr;93:233-236. doi: 10.1016/j.ijid.2020.02.049. Epub 2020 Feb 28. Int J Infect Dis. 2020. PMID: 32119980 Free PMC article. No abstract available.
BIOMARKERS: CAN THEY REALLY GUIDE OUR DAILY PRACTICE?
Tsangaris I, Antonakos N, Fantoni M, Kaplanski G, Kyriazopoulou E, Veas F, Clemens M. Tsangaris I, et al. Among authors: veas f. Shock. 2023 Mar 1;59(3S Suppl 1):16-20. doi: 10.1097/SHK.0000000000001957. Epub 2022 Jul 24. Shock. 2023. PMID: 36867757
Long-term Sudan virus Ebola survivors maintain multiple antiviral defense mechanisms.
Sobarzo A, Mone Y, Lang S, Gelkop S, Brangel P, Kuehne AI, McKendry RA, Mell JC, Ahmed A, Davis C, Dye JM, Lutwama JJ, Lobel L, Veas F, Ehrlich GD. Sobarzo A, et al. Among authors: veas f. J Infect Dis. 2023 Dec 8:jiad555. doi: 10.1093/infdis/jiad555. Online ahead of print. J Infect Dis. 2023. PMID: 38066574
Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis.
Kyriazopoulou E, Huet T, Cavalli G, Gori A, Kyprianou M, Pickkers P, Eugen-Olsen J, Clerici M, Veas F, Chatellier G, Kaplanski G, Netea MG, Pontali E, Gattorno M, Cauchois R, Kooistra E, Kox M, Bandera A, Beaussier H, Mangioni D, Dagna L, van der Meer JWM, Giamarellos-Bourboulis EJ, Hayem G; International Collaborative Group for Anakinra in COVID-19. Kyriazopoulou E, et al. Among authors: veas f. Lancet Rheumatol. 2021 Oct;3(10):e690-e697. doi: 10.1016/S2665-9913(21)00216-2. Epub 2021 Aug 9. Lancet Rheumatol. 2021. PMID: 34396156 Free PMC article.
54 results